Jim Z. Li
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 2%
- Epidemiology top 5%
- Co-authors
- Claudie CharbonneauJeffrey D. MillerMason W. RussellKiran GuptaCharles M. BaumRobert J. MotzerSindy T. KimM. Dror Michaelson
- Topics
- Antimicrobial Resistance in Staphylococcus (9 papers)Antibiotic Use and Resistance (6 papers)Bacterial Identification and Susceptibility Testing (6 papers)
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
Jim Z. Li
33 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Pulmonary and Respiratory Medicine 1.5k
- Molecular Biology 1.4k
- Oncology 1.1k
- Cancer Research 766
- Epidemiology 551
Countries citing papers authored by Jim Z. Li
This map shows the geographic impact of Jim Z. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Z. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Z. Li more than expected).
Fields of papers citing papers by Jim Z. Li
This network shows the impact of papers produced by Jim Z. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Z. Li. The network helps show where Jim Z. Li may publish in the future.
Co-authorship network of co-authors of Jim Z. Li
This figure shows the co-authorship network connecting the top 25 collaborators of Jim Z. Li. A scholar is included among the top collaborators of Jim Z. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Z. Li. Jim Z. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 34 | |
| 5 | 17 | |
| 6 | 30 | |
| 7 | 77 | |
| 8 | 9 | |
| 9 | 28 | |
| 10 | 102 | |
| 11 | 70 | |
| 12 | Safety and Efficacy of Topical Ophthalmic CP-690,550, a Janus Kinase Inhibitor, for Dry Eye Disease: A Phase 1/2 Clinical Trial | 1 |
| 13 | 23 | |
| 14 | Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature reviewbreakdown → | 774 |
| 15 | Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinomabreakdown → | 1304 |
| 16 | 19 | |
| 17 | 18 | |
| 18 | 24 | |
| 19 | Effects of linezolid on hospital length of stay compared with vancomycin in treatment of methicillin-resistant Staphylococcus infections. An application of multivariate survival analysis. | 21 |
| 20 | 0 |
About Jim Z. Li
Jim Z. Li is a scholar working on Applied Microbiology and Biotechnology, Family Practice and Clinical Biochemistry, having authored 35 papers that have together received 3.3k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (9 papers), Antibiotic Use and Resistance (6 papers) and Bacterial Identification and Susceptibility Testing (6 papers). The work is most often cited by research in Cancer Research (766 citations), Pulmonary and Respiratory Medicine (1.5k citations) and Oncology (1.1k citations). Jim Z. Li has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Claudie Charbonneau, Jeffrey D. Miller, Mason W. Russell, Kiran Gupta, Charles M. Baum, Robert J. Motzer, Sindy T. Kim, M. Dror Michaelson, Gary R. Hudes and George Wilding. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.